Operating Lease, Right-of-Use Asset in USD of Clearside Biomedical, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Clearside Biomedical, Inc. quarterly Operating Lease, Right-of-Use Asset history and change rate from Q1 2019 to Q3 2025.
  • Clearside Biomedical, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $376,000, a 43.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Clearside Biomedical, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $376,000 -$291,000 -44% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 $452,000 -$284,000 -39% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $525,000 -$278,000 -35% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $597,000 -$272,000 -31% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 $667,000 -$266,000 -29% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $736,000 -$260,000 -26% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $803,000 -$254,000 -24% 31 Mar 2024 10-Q 10 May 2024 2024 Q1
Q4 2023 $869,000 -$248,000 -22% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $933,000 +$707,000 +313% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $996,000 +$720,000 +261% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,057,000 +$733,000 +226% 31 Mar 2023 10-Q 12 May 2023 2023 Q1
Q4 2022 $1,117,000 +$748,000 +203% 31 Dec 2022 10-K 12 Mar 2024 2023 FY
Q3 2022 $226,000 -$186,000 -45% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $276,000 -$176,000 -39% 30 Jun 2022 10-Q 12 Aug 2022 2022 Q2
Q1 2022 $324,000 -$167,000 -34% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $369,000 -$159,000 -30% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 $412,000 -$151,000 -27% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $452,000 -$143,000 -24% 30 Jun 2021 10-Q 10 Aug 2021 2021 Q2
Q1 2021 $491,000 -$136,000 -22% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $528,000 -$128,000 -20% 31 Dec 2020 10-K 11 Mar 2022 2021 FY
Q3 2020 $563,000 -$243,000 -30% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $595,000 -$272,000 -31% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $627,000 -$298,000 -32% 31 Mar 2020 10-Q 08 May 2020 2020 Q1
Q4 2019 $656,000 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 $806,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $867,000 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 $925,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.